VIG Dividend ETF Investment Required for 500 Monthly Income Gold and Silver Settle Lower Amid Persistent Selling Pressure The Pothole Puzzle Britains 186bn Road Repair Backlog and Its Economic Impact Consumer Sentiment Plummets to Record Low in May as Inflation Fears Mount Amid Iran Conflict US Dollar Stabilizes Amid Uncertain Prospects for Peace Negotiations Wall Street Rises as Tech Stocks Rally and USIran Talks Progress CART Q1 2026 Earnings EPS Misses Estimates Despite Strong Operational Execution TUYA Q1 2026 Earnings EPS Slightly Below Estimates Amidst Flat Stock Performance CKX Lands Inc Q1 2025 Earnings Positive EPS Signals Operational Stability Amidst Revenue Uncertainty USAC Q1 2026 Earnings EPS Miss Sends Units Lower as Operational Costs Weigh ENIC Q4 2025 Earnings EPS Beat Exceeds Expectations Amid Mixed Revenue Disclosures ASTI Q1 2026 Earnings Wider Loss than Expected on No Revenue Stock Surges 27 Community Bancorp CMTV Declines Sharply Support at 3686 in Focus AEFC Holds Steady at 1917 Amid Low Volatility FixedIncome Stability in Focus Bitfarms Ltd BITF Holds Steady at 198 as Crypto Mining Sector Watches Key Levels Microsoft MSFT Stalls Near 418 as Investors Weigh Mixed Signals InMed Pharmaceuticals INM Holds Near Support After Marginal Decline AI Technology Divides Filmmakers at Cannes Market Implications for Entertainment Sector ALG Q1 2026 Earnings EPS Surpasses Estimates by 828 Enanta Pharmaceuticals ENTA Edges Higher Testing Resistance Near 1465 GRRR Q4 2025 Earnings EPS Misses Estimates by Wide Margin as Revenue Remains Undisclosed Michael Burrys Scion Asset Management Discloses New Stake in Alibaba BABA APWC Q3 1997 Earnings EPS Misses Estimates Shares Edge Higher Abercrombie Fitch ANF Q1 2026 Earnings Solid EPS Beat Lifts Shares as Retailer Navigates Cautious Consumer Environment CCL Q1 2026 Earnings Cruise Operator Beats EPS Estimates Amid Strong Demand Pluri Inc PLUR Q1 2026 Earnings WiderthanExpected Loss Sends Shares Lower Vivani Medical Q1 2026 Earnings Slight EPS Beat Fails to Stem Stock Decline as PreRevenue Biotech Navigates Development Pipeline